NCT02291861 - Addressing Involuntary Movements in Tardive Dyskinesia | Biotech Hunter

Enrollment

298

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 19, 2016

Study Completion Date

August 19, 2016

Conditions

Tardive Dyskinesia

Interventions

DRUG

SD-809

SD-809 tablets dose titrated for 4 weeks until target randomized dose is reached. The dose is maintained for an additional 8 weeks. Tablets were swallowed whole with water and taken with food.

DRUG

Placebo

Placebo tablets taken twice daily for 12 weeks. Tablets were swallowed whole with water and taken with food.

Trial Locations (106)

1135

Teva Investigational Site 538, Budapest

1148

Teva Investigational Site 541, Budapest

1204

Teva Investigational Site 537, Budapest

6300

Teva Investigational Site 545, Kalocsa

6725

Teva Investigational Site 547, Szeged

8482

Teva Investigational Site 539, Doba

9024

Teva Investigational Site 546, Győr

10032

Teva Investigational Site 148, New York

11725

Teva Investigational Site 172, Commack

16000

Teva Investigational Site 530, Prague

20007

Teva Investigational Site 156, Washington D.C.

21061

Teva Investigational Site 101, Glen Burnie

21287

Teva Investigational Site 154, Baltimore

22903

Teva Investigational Site 171, Charlottesville

28805

Teva Investigational Site 138, Asheville

29425

Teva Investigational Site 133, Charleston

30033

Teva Investigational Site 165, Decatur

30912

Teva Investigational Site 155, Augusta

32025

Teva Investigational Site 150, Lake City

32607

Teva Investigational Site 117, Gainesville

32803

Teva Investigational Site 112, Orlando

33135

Teva Investigational Site 153, Miami

33165

Teva Investigational Site 162, Miami

33486

Teva Investigational Site 157, Boca Raton

33980

Teva Investigational Site 144, Port Charlotte

35404

Teva Investigational Site 145, Tuscaloosa

38163

Teva Investigational Site 149, Memphis

53188

Teva Investigational Site 166, Waukesha

55131

Teva Investigational Site 504, Mainz

60611

Teva Investigational Site 131, Chicago

60612

Teva Investigational Site 113, Chicago

63104

Teva Investigational Site 175, St Louis

63109

Teva Investigational Site 161, St Louis

63141

Teva Investigational Site 118, Creve Coeur

64108

Teva Investigational Site 142, Kansas City

66160

Teva Investigational Site 164, Kansas City

76104

Teva Investigational Site 151, Fort Worth

77709

Teva Investigational Site 501, Wolfach

80113

Teva Investigational Site 129, Englewood

83209

Teva Investigational Site 507, Prien am Chiemsee

83527

Teva Investigational Site 503, Haag in Oberbayern

84105

Teva Investigational Site 115, Salt Lake City

84108

Teva Investigational Site 141, Salt Lake City

84416

Teva Investigational Site 544, Taufkirchen

87106

Teva Investigational Site 128, Albuquerque

90033

Teva Investigational Site 121, Los Angeles

90650

Teva Investigational Site 174, Norwalk

91206

Teva Investigational Site 123, Glendale

92056

Teva Investigational Site 170, Oceanside

92108

Teva Investigational Site 110, San Diego

92251

Teva Investigational Site 177, Imperial

92354

Teva Investigational Site 176, Loma Linda

92408

Teva Investigational Site 104, San Bernardino

92614

Teva Investigational Site 160, Irvine

92697

Teva Investigational Site 106, Irvine

92804

Teva Investigational Site 107, Anaheim

92805

Teva Investigational Site 108, Anaheim

92868

Teva Investigational Site 102, Orange

94901

Teva Investigational Site 169, San Rafael

99352

Teva Investigational Site 167, Richland

90095-1769

Teva Investigational Site 147, Los Angeles

06519

Teva Investigational Site 139, New Haven

02215

Teva Investigational Site 135, Boston

68526-9467

Teva Investigational Site 178, Lincoln

Unknown

Teva Investigational Site 146, Raleigh

Teva Investigational Site 556, Hostivice

Teva Investigational Site 540, Balassagyarmat

05401

Teva Investigational Site 168, Burlington

736 01

Teva Investigational Site 559, Havířov

503 41

Teva Investigational Site 558, Hradec Králové

412 01

Teva Investigational Site 535, Litoměřice

312 00

Teva Investigational Site 557, Pilsen

100 00

Teva Investigational Site 533, Prague

158 00

Teva Investigational Site 532, Prague

181 02

Teva Investigational Site 531, Prague

190 00

Teva Investigational Site 534, Prague

07551

Teva Investigational Site 502, Gera

H-1135

Teva Investigational Site 542, Budapest

97-400

Teva Investigational Site 514, Bełchatów

15-756

Teva Investigational Site 554, Bialystok

85-015

Teva Investigational Site 510, Bydgoszcz

85-080

Teva Investigational Site 519, Bydgoszcz

85-156

Teva Investigational Site 536, Bydgoszcz

86-200

Teva Investigational Site 523, Chełmno

16-070

Teva Investigational Site 517, Choroszcz

80-952

Teva Investigational Site 513, Gdansk

40-097

Teva Investigational Site 512, Katowice

40-123

Teva Investigational Site 552, Katowice

30-349

Teva Investigational Site 520, Krakow

31-505

Teva Investigational Site 509, Krakow

90-130

Teva Investigational Site 508, Lodz

20-064

Teva Investigational Site 511, Lublin

20-090

Teva Investigational Site 515, Lublin

20-831

Teva Investigational Site 524, Lublin

10-443

Teva Investigational Site 549, Olsztyn

05-802

Teva Investigational Site 521, Pruszków

41-200

Teva Investigational Site 518, Sosnowiec

87-100

Teva Investigational Site 522, Torun

00-465

Teva Investigational Site 550, Warsaw

00-669

Teva Investigational Site 555, Warsaw

50-227

Teva Investigational Site 516, Wroclaw

826 06

Teva Investigational Site 529, Bratislava

935 61

Teva Investigational Site 525, Domaša

04017

Teva Investigational Site 527, Košice

979 12

Teva Investigational Site 528, Rimavská Sobota

04801

Teva Investigational Site 526, Rožňava